The global pharmaceutical industry experienced an 8% rise in company filings mentions of internet of things in Q3 2023 compared with the previous quarter, with the highest share accounted for by Dr. Reddy’s Laboratories with 1100% year-on-year increase, according to GlobalDataâ€™s analysis of over 56 pharmaceutical company filings. GlobalData’s Pharma: Filings Trends & Signals Q3 2023 report delves into earnings call transcripts and quarterly reports within the pharmaceuticals industry, extracting trends, signals, and comparative data to help businesses assess their performance, identify competitive intelligence, evaluate risks, and gain a comprehensive understanding of key industry events. Buy the report here.
Notably, internet of things was one of the most frequently referenced themes in Q3 2023, ranking highest in terms of mentions, ahead of connected care and metaverse, according to GlobalData.
Of the top leading companies in the pharmaceutical industry, Dr. Reddy's Laboratories had the greatest increase in references for internet of things in Q3 2023, compared with the previous quarter. GlobalData identified 12 internet of things-related sentences in the company's filings - 0.2% of all sentences - and an increase of 1100% in Q3 2023 compared with Q3 2022. Merckâ€™s mentions of internet of things to 2 and Pfizerâ€™s by 33% to 2 and United Therapeuticsâ€™s by 100% to 2.
GlobalDataâ€™s Company Filings Analytics also applies sentiment weight to reference sentences, based on whether the sentences are positive, negative, or neutral. Starting at 100 in 2020, an index over 100 is more positive. The overall index for internet of things in Q3 2023 was 89.
For further understanding of GlobalData's Pharma: Filings Trends & Signals Q3 2023, buy the report here.